AVEO Pharmaceuticals (AVEO) Tops Q4 EPS by 28c, Offers Guidance
Tweet Send to a Friend
AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q4 EPS of ($0.49), $0.28 better than the analyst estimate of ($0.77). Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
